![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MERCK'S GARDASIL MAY GIVE WIDER CANCER PROTECTION AND GLAXOSMITHKLINE'S VACCINE "COULD CUT CERVICAL CANCER DEATHS 76 PCT"
MERCK'S GARDASIL MAY GIVE WIDER CANCER PROTECTION AND GLAXOSMITHKLINE'S VACCINE "COULD CUT CERVICAL CANCER DEATHS 76 PCT"
The world's first cervical cancer vaccine may give wider protection against the killer disease than previously thought, researchers said on Sunday. New
data presented at a medical conference in Prague showed Merck & Co Inc's
Gardasil had the potential to neutralise additional strains of the sexually
transmitted human papillomavirus (HPV) that causes the disease. Gardasil is
already approved for sale in the United States and is awaiting approval in Europe.
Financial
News USA
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct